@article{67dc70b231114a0cb1c2f2039d5c44bc,
title = "Reply to T.M. Weis et al",
author = "Bartlett, {Nancy L.} and Wilson, {Wyndham H.} and Leonard, {John P.}",
note = "Funding Information: John P. Leonard Consulting or Advisory Role: Celgene, Biotest, Sunesis Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, Epizyme, Pfizer, Bayer, Genentech, ADC Therapeutics, MEI Pharma, AstraZeneca, Novartis, Merck, Sutter Medical Group, MorphoSys, BeiGene, Nordic Nanovector, Bristol-Myers Squibb, United Therapeutics, Karyopharm Therapeutics, Sandoz Research Funding: Celgene (Inst), Alliance for Clinical Trials in Oncology (Inst), Takeda (Inst), Pfizer (Inst), National Cancer Institute (Inst) Travel, Accommodations, Expenses: BeiGene",
year = "2019",
doi = "10.1200/JCO.19.01617",
language = "English",
volume = "37",
pages = "2953",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
number = "31",
}